238 related articles for article (PubMed ID: 30830574)
1. Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources.
Pladevall-Vila M; Pottegård A; Schink T; Reutfors J; Morros R; Poblador-Plou B; Timmer A; Forns J; Hellfritzsch M; Reinders T; Hägg D; Giner-Soriano M; Prados-Torres A; Cainzos-Achirica M; Hallas J; Brandt L; Cortés J; Aguado J; Perlemuter G; Falissard B; Castellsagué J; Jacquot E; Deltour N; Perez-Gutthann S
CNS Drugs; 2019 Apr; 33(4):383-395. PubMed ID: 30830574
[TBL] [Abstract][Full Text] [Related]
2. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
3. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.
Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M
CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758
[TBL] [Abstract][Full Text] [Related]
5. Agomelatine: new drug. Adverse effects and no proven efficacy.
Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant use in Denmark, Germany, Spain, and Sweden between 2009 and 2014: Incidence and comorbidities of antidepressant initiators.
Forns J; Pottegård A; Reinders T; Poblador-Plou B; Morros R; Brandt L; Cainzos-Achirica M; Hellfritzsch M; Schink T; Prados-Torres A; Giner-Soriano M; Hägg D; Hallas J; Cortés J; Jacquot E; Deltour N; Perez-Gutthann S; Pladevall M; Reutfors J
J Affect Disord; 2019 Apr; 249():242-252. PubMed ID: 30780117
[TBL] [Abstract][Full Text] [Related]
7. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
[TBL] [Abstract][Full Text] [Related]
8. Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
Ishtiak-Ahmed K; Musliner KL; Christensen KS; Mortensen EL; Nierenberg AA; Gasse C
Am J Psychiatry; 2024 Jan; 181(1):47-56. PubMed ID: 37849303
[TBL] [Abstract][Full Text] [Related]
9. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.
Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA
Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
12. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Llorca PM; Lançon C; Brignone M; Rive B; Salah S; Ereshefsky L; Francois C
Curr Med Res Opin; 2014 Dec; 30(12):2589-606. PubMed ID: 25249164
[TBL] [Abstract][Full Text] [Related]
13. Paroxetine versus other anti-depressive agents for depression.
Purgato M; Papola D; Gastaldon C; Trespidi C; Magni LR; Rizzo C; Furukawa TA; Watanabe N; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006531. PubMed ID: 24696195
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of vortioxetine versus agomelatine, categorized by previous treatment, in patients with major depressive disorder switched after an inadequate response.
Papakostas GI; Nielsen RZ; Dragheim M; Tonnoir B
J Psychiatr Res; 2018 Jun; 101():72-79. PubMed ID: 29554497
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of agomelatine in previously-treated depressed patients.
Kasper S; Hajak G
Eur Neuropsychopharmacol; 2013 Aug; 23(8):814-21. PubMed ID: 23820051
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
17. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2-year long-term nation-wide population-based study emulating a randomized trial.
Kessing LV; Ziersen SC; Andersen FM; Gerds T; Budtz-Jørgensen E
Acta Psychiatr Scand; 2024 May; 149(5):378-388. PubMed ID: 38379028
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
19. The effects of agomelatine on sexual function in depressed patients and healthy volunteers.
Montejo A; Majadas S; Rizvi SJ; Kennedy SH
Hum Psychopharmacol; 2011 Dec; 26(8):537-42. PubMed ID: 22102540
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine versus other anti-depressive agents for depression.
Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
